申请人:——
公开号:US20040214870A1
公开(公告)日:2004-10-28
The present invention is directed to compounds of formula (I),
1
or a pharmaceutically suitable salt or prodrug thereof, which are useful for the selective inhibition of protein tyrosine phosphatase-1B (PTP1B), and are useful for the treatment of disorders caused by overexpressed or altered protein tyrosine phosphatase 1B.
本发明涉及式(I)的化合物,或其药用适宜盐或前药,用于选择性抑制蛋白酪氨酸磷酸酶-1B(PTP1B),并且用于治疗由过度表达或改变的蛋白酪氨酸磷酸酶1B引起的疾病。